GlassScriptPhysician profile
Brooke L Wacker
NPI 1033771563
$1,309.77
in general payments reported to CMS, 2019-2025
21 companies · $490 in 2025
The $490 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $221 · 2022: $336 · 2023: $88.82 · 2024: $173 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $752.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $181.17 | 2024-2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $178.48 | 2021-2025 | Invega Sustenna, Spravato |
| Alkermes, INC. | $153.41 | 2023-2025 | Lybalvi, Aristada, Vivitrol |
| Abbvie INC. | $148.06 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $127.45 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $79.22 | 2022-2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $69.91 | 2025 | Cobenfy |
| Corium, LLC | $62.95 | 2024-2025 | Azstarys |
| Neurocrine Biosciences, INC. | $38.83 | 2022-2025 | |
| Avanir Pharmaceuticals, INC. | $34.51 | 2022 | |
| Eisai INC. | $31.47 | 2021 | |
| Vanda Pharmaceuticals INC. | $28.27 | 2025 | Hetlioz, Fanapt |
| Amarin Pharma, INC. | $23.71 | 2021 | |
| Almatica Pharma LLC | $22.65 | 2025 | Loreev Xr |
| Bausch Health US, LLC | $22.28 | 2025 | Aplenzin |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $21.13 | 2025 | Trintellix |
| Idorsia Pharmaceuticals US INC | $20.70 | 2025 | Quviviq |
| Ironshore Pharmaceuticals INC. | $18.19 | 2024 | |
| Collegium Pharmaceutical, INC. | $17.57 | 2025 | Jornay Pm |
| Hologic Sales and Service, LLC | $15.69 | 2021 | |
| Sun Pharmaceutical Industries INC. | $14.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Wacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.